NO771124L - Fremgangsm}te ved fremstilling av uracilderivater - Google Patents

Fremgangsm}te ved fremstilling av uracilderivater

Info

Publication number
NO771124L
NO771124L NO771124A NO771124A NO771124L NO 771124 L NO771124 L NO 771124L NO 771124 A NO771124 A NO 771124A NO 771124 A NO771124 A NO 771124A NO 771124 L NO771124 L NO 771124L
Authority
NO
Norway
Prior art keywords
fluoro
hexahydro
dioxopyrimidine
carboxylate
ethyl
Prior art date
Application number
NO771124A
Other languages
English (en)
Norwegian (no)
Inventor
Osamu Miyashita
Koichi Matsumura
Hiroshi Shimadzu
Naoto Hashimoto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3665376A external-priority patent/JPS52118480A/ja
Priority claimed from JP12993276A external-priority patent/JPS5353672A/ja
Priority claimed from JP14679576A external-priority patent/JPS5371086A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO771124L publication Critical patent/NO771124L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
    • C07C273/1854—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas by reactions not involving the formation of the N-C(O)-N- moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO771124A 1976-03-31 1977-03-30 Fremgangsm}te ved fremstilling av uracilderivater NO771124L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3665376A JPS52118480A (en) 1976-03-31 1976-03-31 Synthesis of uracil derivatives
JP12993276A JPS5353672A (en) 1976-10-27 1976-10-27 Fluoropyrimidine deivatives
JP14679576A JPS5371086A (en) 1976-12-06 1976-12-06 Preparation of uracil derivs.

Publications (1)

Publication Number Publication Date
NO771124L true NO771124L (no) 1977-10-03

Family

ID=27289176

Family Applications (1)

Application Number Title Priority Date Filing Date
NO771124A NO771124L (no) 1976-03-31 1977-03-30 Fremgangsm}te ved fremstilling av uracilderivater

Country Status (18)

Country Link
US (1) US4329460A (xx)
CA (1) CA1081226A (xx)
CH (1) CH632748A5 (xx)
DD (2) DD137353A5 (xx)
DE (1) DE2714392A1 (xx)
DK (1) DK142029B (xx)
ES (1) ES469098A1 (xx)
FI (1) FI770904A (xx)
FR (1) FR2346337A1 (xx)
GB (1) GB1546346A (xx)
GR (1) GR68935B (xx)
NL (1) NL7703541A (xx)
NO (1) NO771124L (xx)
PH (1) PH14553A (xx)
PL (1) PL106917B1 (xx)
PT (1) PT66374B (xx)
SE (1) SE7703721L (xx)
SU (1) SU795467A3 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57179188A (en) * 1981-04-28 1982-11-04 Shionogi & Co Ltd 5-fluorouracil derivative
DK167280B1 (da) * 1985-03-20 1993-10-04 Ciba Geigy Ag 3-aryluracilderivater, fremgangsmaade til fremstilling deraf, ukrudtsbekaempelsesmidler indeholdende disse derivater samt anvendelsen af derivaterne til ukrudtsbekaempelse
US4669081A (en) * 1986-02-04 1987-05-26 Raytheon Company LSI fault insertion
US4816585A (en) * 1987-03-05 1989-03-28 Olin Corporation Tetraalkylpiperidinyl substituted uracil derivatives and their use as ultraviolet light stabilizers
US4904714A (en) * 1987-10-02 1990-02-27 Olin Corporation Synthetic resin composition and its method of use
US4920126A (en) * 1988-05-10 1990-04-24 Uniroyal Chemical Ltd/Uniroyal Chemical Ltee Barbituric acid derivative and treatment of leukemia and tumors therewith
US5312919A (en) * 1992-06-12 1994-05-17 Baylor Research Institute Photooxidation products and derivatives thereof of merocyanine-540, their preparation and uses

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3221010A (en) * 1963-05-02 1965-11-30 Hoffmann La Roche 5,6-substituted dihydro-5-fluoropyrimidine nucleosides
US3277092A (en) * 1963-05-02 1966-10-04 Hoffmann La Roche 5, 6-substituted dihydro-5-fluoropyrimidines
US3201387A (en) * 1963-09-18 1965-08-17 Heidelberger Charles 5-trifluoromethyluracil, derivatives thereof, and processes for preparing the same
US3360523A (en) * 1964-06-17 1967-12-26 Du Pont 3, 5, 6-substituted hydrouracils
US3406023A (en) * 1966-10-31 1968-10-15 Du Pont Herbicidal method
US3954758A (en) * 1970-05-27 1976-05-04 Pcr, Inc. Process for fluorinating uracil and derivatives thereof
CH553195A (de) * 1971-03-19 1974-08-30 Sandoz Ag Verfahren zur herstellung neuer 2,6-dichlor-benzaldoximo-(s-triazinyl-(6))-aether.
US3987045A (en) * 1971-05-03 1976-10-19 Basf Aktiengesellschaft Disperse dyes based on isoindolene derivatives
US3954759A (en) * 1972-07-13 1976-05-04 Pcr, Inc. Process for preparation of 6-substituted 5-fluorouracil derivatives
DE2401619C2 (de) * 1974-01-14 1986-04-03 Kailash Kumar Prof. Dr. 2359 Lentföhrden Gauri Fungistatisch wirksame Uracilderivate und Verfahren zu ihrer Herstellung
DE2602175B2 (de) * 1975-01-22 1978-05-03 Asahi Kasei Kogyo K.K., Osaka (Japan) 1 -Alkanoyl-5-fluor-uracilderivate und ihre Verwendung
US4071519A (en) * 1975-11-05 1978-01-31 Mitsui Toatsu Chemicals, Incorporated 1-Carbamoyl-5-fluorouracil derivatives
US4080455A (en) * 1975-12-16 1978-03-21 Taisho Pharmaceutical Company Limited 5-Fluoropyrimidin-4-one compositions

Also Published As

Publication number Publication date
ES469098A1 (es) 1979-09-16
DE2714392A1 (de) 1977-12-22
PT66374B (en) 1978-08-25
SU795467A3 (ru) 1981-01-07
FR2346337B1 (xx) 1983-05-13
CA1081226A (en) 1980-07-08
DK142029C (xx) 1981-01-05
PL106917B1 (pl) 1980-01-31
PL197045A1 (pl) 1978-02-13
DK141177A (xx) 1977-10-01
CH632748A5 (de) 1982-10-29
FR2346337A1 (fr) 1977-10-28
GR68935B (xx) 1982-03-29
SE7703721L (sv) 1977-10-01
PT66374A (en) 1977-04-01
US4329460A (en) 1982-05-11
DD132790A5 (de) 1978-11-01
GB1546346A (en) 1979-05-23
NL7703541A (nl) 1977-10-04
PH14553A (en) 1981-09-24
DK142029B (da) 1980-08-11
FI770904A (xx) 1977-10-01
DD137353A5 (de) 1979-08-29

Similar Documents

Publication Publication Date Title
NO167805B (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive estere av 9-(2-hydroksyetoksymetyl)guanin.
PT90159B (pt) Processo para a preparacao de bis(hidroximetil) ciclobutil purinas e pirimidinas
NO161116B (no) Analogifremgangsmaate for fremstilling av antiviralt virksomme purinderivater.
CN100358892C (zh) 7-氧代吡啶并嘧啶
DE69419328T2 (de) Antivirale Tetrahydropyrane
KR940008848B1 (ko) 신규의 9-디아자구아닌
NO771124L (no) Fremgangsm}te ved fremstilling av uracilderivater
Hsu et al. Synthesis of anti-restricted pyrimidine acyclic nucleosides
EP3369733A1 (en) Crystal form of 4h-pyrazolo[1,5- ]benzoimidazole compound, preparation method therefor and intermediate thereof
US4048307A (en) Cyclic adenosine monophosphate 8-substituted derivatives
EP0102175A1 (en) 5-Oxo-5H-(1)benzopyrano(2,3-b)pyridine derivatives, their production and use
Silverman et al. A mild method of hydrolysis of 2, 4-dialkoxy-6-substituted pyrimidines to 6-substituted uracils
Burch Nitrofuryl heterocycles. VII. 4-Amino-6-(5-nitro-2-furyl)-1H-pyrazolo [3, 4-d] pyrimidines
Lee et al. Antitumor agents. 86. Synthesis and cytotoxicity of. alpha.-methylene-. gamma.-lactone-bearing purines
KR820000231B1 (ko) 우라실 유도체의 제조방법
US5717086A (en) Preparation of fluoro-nucleosides and intermediates for use therein
GB2211185A (en) Uridine derivatives and antiviral agents containing them
Settimo et al. Synthesis of purinobenzothiazine and pyridothiazinopurine derivatives. Two new heterocyclic ring systems
SU847917A3 (ru) Способ получени производных урацила
US4447605A (en) Di(tri-lower alkylstannyl)pyrimidine derivative and a process for producing the same
WO2023093812A1 (zh) 三氮唑酮类化合物的晶型及其应用
CN110950848B (zh) 新型氨基吡唑类衍生物的合成与应用
US4324895A (en) Novel process for producing pyrimidine nucleosides and novel pyrimidine nucleosides obtained thereby
AT355046B (de) Verfahren zur herstellung von neuen 5-fluor- dihydrouracilen
HU209437B (en) Process for producing purinyl and pyrimidinyl tetrahydrofuran derivatives and pharmaceutical preparations containing them